Pulmair Medical, Inc.
Clinical trials sponsored by Pulmair Medical, Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Artificial bronchus implant aims to open blocked airways in severe emphysema Results expected Jul 2027 (estimated)
- New lung implant could help severe emphysema patients breathe easier Results expected Aug 2027 (estimated)
-
New lung implant could help severe emphysema patients breathe easier
Disease control Recruiting nowThis study tests a new device called the IAB 50 Flex, an implantable artificial bronchus for adults with severe COPD or emphysema. The trial will enroll 20 participants across two hospitals to check if the implant is safe and if it helps improve breathing and daily activity. The …
Sponsor: Pulmair Medical, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
Artificial bronchus implant aims to open blocked airways in severe emphysema
Disease control Recruiting nowThis study tests a new device called an implantable artificial bronchus (IAB) for people with severe emphysema or COPD. The IAB is designed to help air move in and out of the lungs more easily. About 60 adults will receive the implant and be followed for 90 days to see if it impr…
Sponsor: Pulmair Medical, Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC